118 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
responsibility or liability with respect to any of its obligations (including any payment obligations) under the Local Agreements (including for any … will be the responsibility of Fennec.
FINANCIAL MATTERS
Fees and Other Payments
Up Front Fee. Licensee shall pay to Fennec on the Effective Date, as one-time, non
424B7
FENC
Fennec Pharmaceuticals Inc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
statements are representative only as of the date they are made, and we assume no responsibility to update any forward-looking statements except as required … they are made, and we assume no responsibility to update any forward-looking statements except as required by law. The forward-looking statements
424B3
o4ba1x48tyy33buro
15 Dec 22
Prospectus supplement
5:12pm
8-K
EX-10.1
8fqu7mcyep3i8alb
1 Aug 22
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
4:15pm